IDT Australia Tightens Governance with Revised Security Trading Policy

The latest announcement is out from IDT Australia Limited ( (AU:IDT) ).

IDT Australia Limited has updated its Security Trading Policy in line with ASX Listing Rule 12.10, reflecting the company’s ongoing focus on regulatory compliance and governance standards in its role as a specialist contract pharmaceutical manufacturer. The revised policy, now available on the company’s website, sets out refreshed rules and definitions governing trading in the company’s securities by key management and related parties, underscoring a tighter framework around insider trading and market-sensitive information that is likely to be welcomed by regulators and investors alike.

The most recent analyst rating on (AU:IDT) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on IDT Australia Limited stock, see the AU:IDT Stock Forecast page.

More about IDT Australia Limited

IDT Australia Limited is an Australian pharmaceutical manufacturing company based in Boronia, Victoria, specialising in the development and production of high potency and high containment pharmaceutical products for local and international clients. Its cGMP-compliant facilities, regularly audited by the US FDA and Australian TGA, support full-scale services spanning new drug development, scale-up, active pharmaceutical ingredient manufacture and a range of oral and injectable finished dose forms.

Average Trading Volume: 194,312

Technical Sentiment Signal: Sell

Current Market Cap: A$18.51M

Learn more about IDT stock on TipRanks’ Stock Analysis page.